Showing results (61-70 of 3,361) with videos related to
Sort By:
Pageof 337
Antimicrobial Agents and Chemotherapy|December 1, 1979
Fortimicin A: collaborative in vitro susceptibility. Comparison with amikacin and gentamicin against 11,840 clinical bacterial isolatesR N Jones, A L Barry, P C Fuchs, et al.Antimicrobial Agents and Chemotherapy|April 1, 1980
Cefoperazone (T-1551), a new semisynthetic cephalosporin: comparison with cephalothin and gentamicinR N Jones, P C Fuchs, A L Barry, et al.Antimicrobial Agents and Chemotherapy|December 1, 1986
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolatesR N Jones, P C Fuchs, A L Barry, et al.Antimicrobial Agents and Chemotherapy|May 1, 1987
Antimicrobial activity of ceftriaxone, cefotaxime, desacetylcefotaxime, and cefotaxime-desacetylcefotaxime in the presence of human serumR N Jones, A L BarryDiagnostic Microbiology and Infectious Disease|December 1, 1987
In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibitionR N Jones, A L BarryThe Journal of Antimicrobial Chemotherapy|November 1, 1988
Interpretative criteria for the agar diffusion susceptibility test with azithromycinA L Barry, R N JonesAntimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L BarryJournal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L BarryAntimicrobial Agents and Chemotherapy|October 1, 1988
Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporinR N Jones, A L BarryAntimicrobial Agents and Chemotherapy|June 1, 1984
Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populationsA L Barry, R N JonesPageof 337